VEGF is an essential retrograde trophic factor for motoneurons

Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2202912119. doi: 10.1073/pnas.2202912119. Epub 2022 Jun 21.

Abstract

VEGF was initially discovered due to its angiogenic activity and therefore named "vascular endothelial growth factor." However, its more recently discovered neurotrophic activity may be evolutionarily more ancient. Our previous work showed that all the changes produced by axotomy on the firing activity and synaptic inputs of abducens motoneurons were completely restored after VEGF administration. Therefore, we hypothesized that the lack of VEGF delivered by retrograde transport from the periphery should also affect the physiology of otherwise intact abducens motoneurons. For VEGF retrograde blockade, we chronically applied a neutralizing VEGF antibody to the lateral rectus muscle. Recordings of extracellular single-unit activity and eye movements were made in alert cats before and after the application of the neutralizing antibody. Our data revealed that intact, noninjured abducens motoneurons retrogradely deprived of VEGF exhibited noticeable changes in their firing pattern. There is a general decrease in firing rate and a significant reduction in eye position and eye velocity sensitivity (i.e., a decrease in the tonic and phasic components of their discharge, respectively). Moreover, by means of confocal immunocytochemistry, motoneurons under VEGF blockade showed a marked reduction in the density of afferent synaptic terminals contacting with their cell bodies. Altogether, the present findings demonstrate that the lack of retrogradely delivered VEGF renders abducens motoneurons into an axotomy-like state. This indicates that VEGF is an essential retrograde factor for motoneuronal synaptic drive and discharge activity.

Keywords: abducens; axotomy; neurotrophic factors; oculomotor; synaptic stripping.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Axotomy
  • Cats
  • Eye Movements* / drug effects
  • Eye Movements* / physiology
  • Motor Neurons* / drug effects
  • Motor Neurons* / physiology
  • Oculomotor Muscles / drug effects
  • Oculomotor Muscles / physiology
  • Presynaptic Terminals* / drug effects
  • Presynaptic Terminals* / physiology
  • Vascular Endothelial Growth Factor A* / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A* / pharmacology
  • Vascular Endothelial Growth Factor A* / physiology

Substances

  • Antibodies, Neutralizing
  • Vascular Endothelial Growth Factor A